Ophthalmic centre Moorfields Eye Hospital Dubai (Moorfields) disclosed on Sunday that it has appointed Dr Luisa M Sastre, MD, PhD, Specialist Ophthalmologist in Medical Retina, to its Dubai-based team of medical specialists.
The hospital said Dr Sastre is a highly experienced Ophthalmologist with a special interest in retinal diseases and especially diabetes-related disorders, who has performed many intravitreal injections for diabetes patients and a large number of surgeries for cataract patients, as well as other procedures such as pterygium and minor lid surgeries. She is also experienced in treating children and in the treatment of other eye diseases such as glaucoma.
Dr Sastre has held several posts as a Consultant Ophthalmologist and as an Intensive Care Specialist in private and public hospitals in Madrid, Spain, before relocating to Dubai. She has also undertaken medical teaching and charitable activities related to her clinical work.
Moorfields Eye Hospital Dubai (MEHD) is the first overseas branch of Moorfields Eye Hospital NHS Foundation Trust, the oldest and one of the largest centres for ophthalmic treatment, teaching and research in the world. MEHD is located at the Al Razi Medical Complex in Dubai Health Care City. It provides day case surgery and outpatient diagnostic and treatment services, for a variety of surgical and non-surgical eye conditions.
vTv Therapeutics secures USD51m private placement for cadisegliatin Phase 3 study
AbbVie names new chief executive officer
SkinBioTherapeutics expands foot care products in AMEA with Dermatonics partnership
Diamyd Medical granted US FDA Fast Track designation for Diamyd diabetes treatment
Insulet's Omnipod 5 integration with Abbott FreeStyle Libre 2 Plus Sensor secures CE Mark approval
Kyowa Kirin enrols first subject in phase two tivozanib eye drops (KHK4951) clinical trial
China accepts GSK's Shingrix application for at-risk adults
Novo Nordisk to boost manufacturing capacity with acquisition of three fill-finish sites
Breye Therapeutics commences phase 1b/2a danegaptide clinical trial
DexCom Inc breaks ground on new manufacturing facility in Ireland
VibroSense Dynamics AB secures provisional patent for chemotherapy-induced nerve damage prediction
Innovent Biologics signs collaboration agreement with Sanegene Bio USA
Japan approves GSK's filing for Arexvy vaccination for at-risk adults